Department of Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.
Int J Psychiatry Med. 2023 Jul;58(4):325-338. doi: 10.1177/00912174231165184. Epub 2023 Mar 16.
Cancer survivors face numerous physical and mental health challenges after treatment completion. However, few studies have examined mental health in cancer survivors who received curative treatment during the transition out of active treatment and into survivorship. The current study describes the mental health outcomes and their correlates in cancer survivors treated with curative intent during the first year of survivorship.
A total of 120 cancer survivors of any cancer type completed a survey that assessed depression, anxiety, death ideation, alcohol and substance use, and demographic characteristics. Data regarding cancer type and treatment were extracted from the medical record.
Approximately 15% of the sample reported depressive symptoms. Fifteen percent also reported anxiety symptoms in the past two weeks. Ten percent of the sample reported experiencing death ideation since their treatment ended and 7.5% reported death ideation in the past two weeks. Younger age, previous psychiatric diagnosis, and current substance use were associated with depressive symptoms, anxiety symptoms, and death ideation.
Cancer survivors entering survivorship after curative treatment experience an increased rate of depressive symptoms, anxiety symptoms, and death ideation. Younger cancer survivors and those with previous psychiatric diagnoses or substance use may be at particular risk for mental health problems during the first year of survivorship. Future research within both oncology and primary care should further examine modifiable risk factors for depression, anxiety, and death ideation in cancer survivors at the transition into survivorship after curative treatment to improve survivorship care.
癌症患者在完成治疗后会面临许多身心健康方面的挑战。然而，很少有研究关注接受根治性治疗的癌症患者在从积极治疗过渡到生存阶段后的心理健康状况。本研究描述了在生存阶段的第一年接受根治性治疗的癌症患者的心理健康结果及其相关因素。
共有 120 名来自任何癌症类型的癌症幸存者完成了一项调查，该调查评估了抑郁、焦虑、死亡意念、酒精和物质使用以及人口统计学特征。癌症类型和治疗相关的数据从病历中提取。
大约 15%的样本报告有抑郁症状。15%的样本在过去两周内也报告有焦虑症状。10%的样本报告在治疗结束后出现过死亡意念，7.5%的样本在过去两周内报告过死亡意念。年龄较小、既往精神科诊断和当前物质使用与抑郁症状、焦虑症状和死亡意念有关。
接受根治性治疗后进入生存阶段的癌症患者会出现更高的抑郁症状、焦虑症状和死亡意念发生率。年轻的癌症幸存者和有既往精神科诊断或物质使用史的患者在根治性治疗后的生存阶段第一年可能面临特定的心理健康问题风险。未来在肿瘤学和初级保健领域的研究应进一步探讨可改变的风险因素，以改善癌症患者在根治性治疗后过渡到生存阶段的生存护理。
